(Q34510969)

2 August 2017

1 reference

title

Structured treatment interruption in patients infected with HIV: a new approach to therapy (English)

1 reference

2 August 2017

Roy M Gulick

1

1 reference

2 August 2017

publication date

1 January 2002

1 reference

2 August 2017

1 reference

2 August 2017

volume

62

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

245-253

1 reference

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

2 August 2017

cites work

1 reference

12 December 2020

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

12 December 2020

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

1 reference

12 December 2020

The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

1 reference

12 December 2020

Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure

1 reference

12 December 2020

Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection.

1 reference

12 December 2020

Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report

1 reference

12 December 2020

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

12 December 2020

Mutation takes no vacation: can structured treatment interruptions increase the risk of drug-resistant HIV-1?

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

1 reference

12 December 2020

HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group

1 reference

12 December 2020

Acute HIV syndrome after discontinuation of antiretroviral therapy in a patient treated before seroconversion

1 reference

12 December 2020

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

1 reference

12 December 2020

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

12 December 2020

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1 reference

12 December 2020

Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption

1 reference

12 December 2020

HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection

1 reference

12 December 2020

Control of HIV despite the Discontinuation of Antiretroviral Therapy

1 reference

12 December 2020

Immune control of HIV-1 after early treatment of acute infection

1 reference

12 December 2020

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

1 reference

12 December 2020

Retroviral rebound syndrome after cessation of suppressive antiretroviral therapy in three patients with chronic HIV infection

1 reference

12 December 2020

Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection

1 reference

12 December 2020

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

1 reference

12 December 2020

Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression

1 reference

12 December 2020

10.2165/00003495-200262020-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1024855546

0 references

1 reference